Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) Co-Administered in Patients With Type IIa or Type IIb Hyperlipidemia
Brief Summary: To evaluate the efficacy and safety of ezetimibe/simvastatin and niacin in patients with high cholesterol.


Options:
A: Arm Label: Part 1 - Arm 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Comparator: ezetimibe/simvastatin + niacin (ER) | Arm Label: Part 1 -Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Comparator: ezetimibe (+) simvastatin, Drug: Comparator: Placebo to Niacin (ER) | Arm Label: Part 1 - Arm 3; Type: ACTIVE_COMPARATOR; Interventions: Drug: Comparator: Placebo to ezetimibe/simvastatin, Drug: Comparator: niacin (ER) tablet | Arm Label: Part 2 - Arm 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Comparator: ezetimibe/simvastatin and niacin (ER) | Arm Label: Part 2 - Arm 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Comparator: ezetimibe and simvastatin, Drug: Comparator: Placebo to niacin (ER) | Intervention Type: DRUG; Name: Comparator: ezetimibe/simvastatin + niacin (ER); Assigned to Arm(s): Part 1 - Arm 1 | Intervention Type: DRUG; Name: Comparator: Placebo to ezetimibe/simvastatin; Assigned to Arm(s): Part 1 - Arm 3 | Intervention Type: DRUG; Name: Comparator: niacin (ER) tablet; Assigned to Arm(s): Part 1 - Arm 3 | Intervention Type: DRUG; Name: Comparator: ezetimibe (+) simvastatin; Assigned to Arm(s): Part 1 -Arm 2 | Intervention Type: DRUG; Name: Comparator: Placebo to Niacin (ER); Assigned to Arm(s): Part 1 -Arm 2 | Intervention Type: DRUG; Name: Comparator: ezetimibe/simvastatin and niacin (ER); Assigned to Arm(s): Part 2 - Arm 1 | Intervention Type: DRUG; Name: Comparator: ezetimibe and simvastatin; Assigned to Arm(s): Part 2 - Arm 2 | Intervention Type: DRUG; Name: Comparator: Placebo to niacin (ER); Assigned to Arm(s): Part 2 - Arm 2
B: Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebos | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Diet, Behavioral: Exercise, Other: Placebos | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Behavioral: Diet, Behavioral: Exercise, Drug: Niacin, Other: Placebos | Arm Label: 4; Type: EXPERIMENTAL; Interventions: Behavioral: Diet, Behavioral: Exercise, Drug: Fenofibrate, Other: Placebos | Arm Label: 5; Type: EXPERIMENTAL; Interventions: Behavioral: Diet, Behavioral: Exercise, Drug: Niacin, Drug: Fenofibrate | Intervention Type: BEHAVIORAL; Name: Diet; Assigned to Arm(s): 2, 3, 4, 5 | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): 2, 3, 4, 5 | Intervention Type: DRUG; Name: Niacin; Assigned to Arm(s): 3, 5 | Intervention Type: DRUG; Name: Fenofibrate; Assigned to Arm(s): 4, 5 | Intervention Type: OTHER; Name: Placebos; Assigned to Arm(s): 1, 2, 3, 4
C: Intervention Type: DRUG; Name: Niacin Extended-Release and simvastatin Tablets; Assigned to Arm(s): N/A
D: Arm Label: ER niacin/laropiprant; Type: EXPERIMENTAL; Interventions: Drug: ER niacin/laropiprant, Drug: simvastatin, Drug: ezetimibe/simvastatin | Arm Label: Placebo; Type: ACTIVE_COMPARATOR; Interventions: Drug: simvastatin, Drug: ezetimibe/simvastatin | Intervention Type: DRUG; Name: ER niacin/laropiprant; Assigned to Arm(s): ER niacin/laropiprant | Intervention Type: DRUG; Name: simvastatin; Assigned to Arm(s): ER niacin/laropiprant, Placebo | Intervention Type: DRUG; Name: ezetimibe/simvastatin; Assigned to Arm(s): ER niacin/laropiprant, Placebo

Answer: A